AGCO CORP /DE (AGCO): what the price requires

At today's price, AGCO CORP /DE (AGCO) is priced for +17.0% growth. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high.

Generated: 2026-07-19 · Source: https://boothcheck.com/report/AGCO

Headline

FieldValue
TickerAGCO
CompanyAGCO CORP /DE
Current price$114.26/sh
CompositionTractors 66% / Replacement parts 19% / Grain storage and protein production systems 0% / Combines, application equipment and other machinery 15%

What The Price Requires (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basiswhole-company
Operating margin needed4.5%
Operating margin today4.7%
Margin compression implied-0.2pp
Implied growth17.0%
Multiple paid24x operating income

The operating-margin requirement is derived from the framework's value band at year 12, a separately labeled basis from the headline growth/duration solve.

Solve inputs: computed at a 8.6% cost of capital with 4% terminal growth over a 5-year stage; each 1pp of cost of capital moves the implied operating-profit growth ~7.5pp.

How unusual the bet is: within-range

ReferenceValue
vs own history+0.12σ
cohort percentile (of 225 peers)56
sustained it ~5 years at this level41%
implied end-window share0%

Valuation X-Ray

The price is supported by asset-based and earnings-power and relative-multiple value, while growth-DCF lands below the price. A value/asset-supported name, not a pure growth bet.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset0.97x5justifies
Earnings1.03x5expensive
Relative0.77x5justifies
Growth1.58x3expensive

Families that justify the price: Asset, Earnings, Relative Families that call it expensive: Growth

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 7.8%); the inversion above states its own rate.

Per-Model Detail (n=18)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth$61.891.85xyesFCF base $0.5B, growth -2% (input: historical growth), terminal g 0.5%, WACC 7.8%, 5yr projection
DCF Exit MultipleGrowth$112.911.01xyesExit EV/EBITDA: 10.3x / 12.3x / 14.3x (bear / base = today's held flat / bull), 5yr
Relative ValuationRelative$148.640.77xyesP/E 18x (static sector reference · 2026-04), scenarios: 15.2x / 18.0x / 20.8x (bear / base = reference held flat / bull), EV/EBITDA 12x
Simple DDMGrowthno
Two-Stage DDMGrowthno
Simple Excess ReturnAsset$114.651.00xyesBV/sh $59.10, ROE (TTM) 17.9%, ke 9.3%
Two-Stage Excess ReturnAsset$157.660.72xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowth$72.191.58xyesRev $10.4B, growth -2% (input: historical growth; tapered), Terminal P/S: 0.7x / 0.8x / 0.9x (bear / base = today's held flat / bull, cap 8x)
Peter Lynch Fair ValueRelative$124.440.92xyesEPS $10.37, growth 2% (input: historical EPS growth), PEG=5.38 (Overvalued)
Margin TrajectoryGrowthno
Earnings Power ValueEarnings$110.821.03xyesNormalized EBIT (5y avg op income, one-time charges added back) $1.01B × (1−21%) / WACC 7.8% → EPV (no growth)
Residual IncomeAsset$156.800.73xyesBV $59.10 + 5yr PV of (ROE (TTM) 17.9% − Kₑ 9.3%) × BV; BV grows 8.8%/yr
Graham NumberAsset$117.430.97xyes√(22.5 × EPS $10.37 × BVPS $59.10) — Graham's conservative floor
EV/EBITDA RelativeRelative$110.611.03xyesEBITDA $0.89B × sector EV/EBITDA 12.0x
FCF YieldEarnings$44.892.55xyesFCF $545.6M / Kₑ 9.3% — zero-growth perpetuity
SBC-Adj FCF YieldEarnings$40.182.84xyesSBC-adj FCF $0.51B (FCF $0.55B − SBC $0.03B) capitalized at Kₑ
Ben Graham FormulaEarnings$334.610.34xyesEPS $10.37 × (8.5 + 2×15.0%) × (4.4 / 5.3%)
ROIC-Justified P/BAsset$6.9816.37xyesBV $59.10 × (ROIC 0.9% / WACC 7.8%)
P/Sales SectorRelative$356.750.32xyesRevenue $10.37B × sector P/S 2.5x
PEG Fair ValueRelative$388.880.29xyesEPS $10.37 × (PEG 1.5 × growth 25.0% (input: historical EPS growth)) → PE 37.5x
Earnings YieldEarnings$112.111.02xyesEPS $10.37 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelativeno
Clinical Phase NPVGrowthno
MertonAssetno
V5 Mechanicalno

Solvency

FieldValue
Net debt$2.5b
Net debt / NOPAT (after-tax)7.17x
Net debt / operating income (pre-tax)5.66x
Share count CAGR (buyback)-0.7%
Burning cashno

Interest expense is not separately reported in the latest filings, so interest coverage cannot be computed.

Bullet Takeaways

AGCO is a global farm-equipment maker (tractors are 66% of the mix, replacement parts 19%, combines and application equipment 15%) whose earnings ride the agricultural-machinery cycle. The business is near the trough of a down-cycle, and the direction is the story: Q1 2026 net sales rose 14.3% to $2.3 billion on a production recovery, and adjusted operating margin improved 50 basis points to 4.6%.

Management lifted its 2026 outlook to $10.5 to $10.7 billion in sales, roughly $6 adjusted EPS, and a 7.5% to 8% adjusted operating margin, while starting a $350 million buyback and raising the dividend 3.4%. The inversion reads the price as embedding about 17% operating growth, which is really cyclical recovery off a trough rather than secular growth.

The constraint is leverage and the cycle: net debt is about $2.5 billion against trailing operating income near $627 million, and 2026 carries a $90 million tariff headwind. The price is supported by the asset and earnings-power families, so this is a value-cyclical name betting on the upturn.

Bull Case

Lead with the earnings trajectory, because AGCO sits at the most important inflection point in a cyclical business: the turn off the trough. Q1 2026 net sales rose 14.3% year over year to $2.3 billion, driven by a production recovery in Europe and North America, and adjusted operating margin improved 50 basis points to 4.6% even with parts of the business still depressed. Management was explicit that the ag-machinery industry is operating around the bottom of its cycle, with dealer inventories normalizing and conditions beginning to set up the next phase of recovery, and it lifted full-year 2026 guidance to $10.5 to $10.7 billion in sales, about $6 in adjusted EPS, and a 7.5% to 8% adjusted operating margin. When a cyclical company raises guidance and grows the top line double digits coming out of a downturn, the direction of margins and cash flow is the signal, and it points up.

The second pillar is the quality of the franchise underneath the cycle, anchored by premium brands and a growing recurring-revenue base. AGCO's Fendt is a premium tractor brand that commands pricing power, and the company is building higher-margin, less-cyclical revenue streams around it. Its filing highlights the aftermarket and services layer, noting that "extended warranty and maintenance services contracts and precision technology services and subscriptions generally have contract" terms that smooth revenue (FY2025 10-K, accession 0000880266-26-000010), and replacement parts have grown to 19% of the mix from 13% over recent years. A larger parts and services base dampens the cyclicality that has historically defined equipment makers, and it is exactly the kind of revenue the market should pay a higher multiple for.

The third pillar is the precision-agriculture growth engine and the capital return that accompanies it. AGCO is integrating PTx, its precision-ag platform built around Trimble technology, and targets $2 billion of PTx revenue by 2029 through new technology, channel activation, and geographic expansion, a secular growth layer on top of the equipment cycle. Alongside, the company started a $350 million buyback in Q2 2026 and raised the dividend 3.4% to $0.30 quarterly, returning cash while the cycle recovers. The valuation methods that capture the franchise support the price: the excess-return and residual-income models land near $115 (June 27, 2026) to $157, the earnings-power value near $111, and the Graham number near $117, all at or above the $113.59 price, so the asset and earnings families say the stock is fairly valued before any cyclical upside.

Bear Case

The structural risk to lead with is the balance sheet carrying a cyclical business through its trough, because that is where a downturn does real damage. AGCO carries net debt of about $2.5 billion against trailing operating income near $627 million, a ratio above 4x, and interest expense is not separately reported in a way that lets a clean coverage ratio be computed. Equipment makers fund large working-capital swings and dealer-financing programs, so leverage rises just as the cycle weakens and sales fall. The company is guiding to a recovery, but if the upturn stalls, a leveraged maker with a depressed margin has far less cushion than the headline guidance implies, and the cash needed to service debt and fund the buyback competes with the working capital a recovery itself would consume.

The second risk is the cyclicality the company cannot escape and the demand backdrop that remains soft. AGCO's own filing is candid that "the unpredictable nature of many of these factors and the resulting volatility in demand make it difficult for us to accurately predict sales" (FY2025 10-K, accession 0000880266-26-000010). Farm-equipment demand is driven by crop prices, farm income, and interest rates, none of which AGCO controls, and management's 2026 framework assumes industry demand at only about 86% of mid-cycle levels with Latin America down sharply, a 30% constant-currency decline in the region in Q1. The 14.3% sales growth was substantially a production-and-restocking recovery rather than end-demand strength, and if farmer purchasing stays cautious, the restocking tailwind fades and the recovery the price assumes does not arrive on schedule.

The third issue is what the conservative methods and the inversion say about the price. The inversion reads the stock as paying about 24x company-wide operating income, implying roughly 17% annual operating growth for five years, and while that pace is within what AGCO has delivered cyclically, the engine notes only about 41% of comparable fast-growers sustained it for five years. The methods that strip out the cyclical recovery are sobering: the perpetual-growth DCF lands near $62 on a negative historical-growth input, the discounted future market cap near $72, and the FCF-yield methods near $40 to $45, all well below price, and the ROIC-justified book value near $7 reflects a reported ROIC barely above 1% at the trough. Add a $90 million tariff headwind in 2026 and European tariff uncertainty, and the bear case is that the price already discounts the recovery while the down-cycle, the leverage, and the trade exposure remain live risks. If the upturn disappoints, the stock looks expensive against its trough earnings.

Valuation

AGCO is a value-cyclical case where the inversion needs reading through the cycle. At $113.59 the price reads as paying about 24x company-wide operating income, implying roughly 17% annual operating growth for five years at an 8.6% cost of capital. That growth rate is really a cyclical recovery off a trough, not secular expansion, and the engine notes the pace is within what AGCO has delivered before, though only about 41% of comparable fast-growers sustained it for five years. The priced-in assumption is characterized as within range.

The model families split between the trough view and the franchise view. The asset and earnings families, which anchor to book value and normalized earnings rather than the depressed trailing quarter, support the price: the simple excess-return model lands near $115, the two-stage version and residual income near $157, the earnings-power value near $111, and the Graham number near $117, all at or above the price. The relative methods also bracket it, with sector P/E near $149 and EV/EBITDA near $111. The growth and cash-flow methods land below price precisely because they extrapolate the recent downturn: the perpetual-growth DCF near $62 on a negative growth input, the discounted future market cap near $72, and the FCF-yield methods near $40 to $45.

The practical read is that AGCO is fairly valued on normalized, mid-cycle economics and looks expensive only if you assume the trough persists. A reader is underwriting the cyclical recovery management guides to, plus the secular precision-ag growth, at today's price. The buyback and dividend are the cash return that pays while the cycle turns, and buying back stock near a fair-to-modest premium to book is reasonable; the risk is leverage and a stalled upturn, not overpayment for the franchise itself.

Catalysts

AGCO reported Q1 2026 results in early May 2026 with net sales up 14.3% to $2.3 billion on a production recovery, adjusted operating margin up 50 basis points to 4.6%, and a stock that rose on the print. Management lifted full-year 2026 guidance to $10.5 to $10.7 billion in sales, roughly $6 in adjusted EPS, and a 7.5% to 8% adjusted operating margin, framing the business as operating around the trough of the cycle. The next quarterly report is the key checkpoint on whether the recovery is end-demand driven or mostly restocking.

The strategic catalyst is precision agriculture. AGCO is integrating its PTx platform around Trimble technology and targets $2 billion of PTx revenue by 2029, a secular growth layer on top of the equipment cycle, alongside continued global expansion of the premium Fendt brand and a growing parts-and-services base. Traction in precision-ag revenue and parts is the signal that the business is becoming less cyclical and more recurring.

Capital return is the live shareholder catalyst: AGCO started a $350 million share buyback in Q2 2026 and raised the dividend 3.4% to $0.30 quarterly. The swing factors are the timing of the ag-equipment recovery, farmer demand tied to crop prices and farm income, and trade policy: management flagged a $90 million tariff headwind for 2026 and European tariff uncertainty. Analyst targets have edged up toward roughly $128, modestly above the current price, reflecting a balanced view of the recovery against tariff and demand risk.

Peer Cohorts (Per Segment, With Filing Citations)

Core business (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

View the full interactive AGCO report on boothcheck